These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11968475)

  • 1. The clinical challenge of posthypoxic myoclonus.
    Frucht SJ
    Adv Neurol; 2002; 89():85-8. PubMed ID: 11968475
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.
    Chadwick D; Hallett M; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():183-90. PubMed ID: 2418645
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment].
    Erro ME; Navarro MC
    Rev Neurol; 2009 Jan; 48 Suppl 1():S1-6. PubMed ID: 19222008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic effect of levetiracetam on posthypoxic myoclonus: difficult weaning from mechanical ventilation.
    Muslu B; Kilci O; Horasanli E; Dikmen B
    Clin Neuropharmacol; 2009; 32(4):236. PubMed ID: 19644236
    [No Abstract]   [Full Text] [Related]  

  • 5. Postanoxic myoclonus: two case presentations and review of medical management.
    Budhram A; Lipson D; Nesathurai S; Harvey D; Rathbone MP
    Arch Phys Med Rehabil; 2014 Mar; 95(3):588-90. PubMed ID: 24060492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer drugs for posthypoxic action myoclonus: observations from a well-studied case.
    Fahn S
    Adv Neurol; 1986; 43():197-9. PubMed ID: 2418646
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effect of piracetam in a case of posthypoxic action myoclonus (author's transl)].
    Terwinghe G; Daumerie J; Nicaise C; Rosillon O
    Acta Neurol Belg; 1978; 78(1):30-6. PubMed ID: 345725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus.
    Hallett M; Chadwick D; Adam J; Marsden CD
    J Neurol Neurosurg Psychiatry; 1977 Mar; 40(3):253-64. PubMed ID: 301926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of piracetam on urea-induced myoclonus in rats].
    Nanri M; Yamamoto A; Matsuura N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases].
    Lay-Son Rivas L; Pizarro Segura J; Meza Flores R
    Neurologia; 2007 Dec; 22(10):915-6. PubMed ID: 18040909
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

  • 12. Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease.
    Imperiale D; Bortolotto S; Cucatto A; Schiffer P; Cassano D; Buffa C
    Eur Neurol; 2003; 49(3):189-90. PubMed ID: 12646771
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report.
    Božić K; Gebauer-Bukurov K; Sakalaš L; Divjak I; Ješić A
    Vojnosanit Pregl; 2014 May; 71(5):515-9. PubMed ID: 26137720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.
    Venot M; Weiss N; Espinoza S; Imbert A; Tadie JM; Fagon JY; Guerot E; Diehl JL
    Intensive Care Med; 2011 Jan; 37(1):177-9. PubMed ID: 20871977
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemistry and therapeutics of posthypoxic myoclonus.
    Van Woert MH; Rosenbaum D; Chung EY
    Adv Neurol; 1986; 43():171-81. PubMed ID: 2418644
    [No Abstract]   [Full Text] [Related]  

  • 16. Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15.
    Orsucci D; Ienco EC; Rocchi A; Siciliano G; Mancuso M; Bonuccelli U
    Mov Disord; 2013 Sep; 28(10):1465. PubMed ID: 23495097
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of levetiracetam in the treatment of two cases of hypoxic encephalopathy with myoclonic status].
    de Gea-García JH; Villegas I; Sánchez Cámara S; Martínez Fresneda M
    Med Intensiva; 2011; 35(6):393-4. PubMed ID: 21296455
    [No Abstract]   [Full Text] [Related]  

  • 18. Rhythmic EMG and EEG activity during voluntary movement in posthypoxic cortical action myoclonus.
    Uozumi T; Tamagawa A; Hashimoto T; Tsuji S
    J UOEH; 2005 Sep; 27(3):227-36. PubMed ID: 16180509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A pharmacological profile of piracetam (Myocalm), a drug for myoclonus].
    Tajima K; Nanri M
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):209-14. PubMed ID: 11084917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus].
    Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc JL; El-Hage W
    Therapie; 1978; 33(5):623-8. PubMed ID: 311085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.